Sign in
4

Changes in Ownership

Arbutus Biopharma Corp Filed Acc 0001123292-19-000435

Options or other derivatives

  • President and CEO acquired 357,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Murray Mark J. · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-03-01 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +357,500 357,500 D
Loading xslF345X03/edgar.xml…